Endocrinology, Vol 134, 736-743, Copyright © 1994 by Endocrine Society

ARTICLES

Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter

R Goswami, R Lacson, E Yang, R Sam and T Unterman
Department of Medicine, University of Illinois College of Medicine, Chicago.

Insulin-like growth factor-binding protein-1 (IGFBP-1) is produced by the liver and regulated by glucocorticoids and insulin at the level of gene transcription. To identify DNA sequences mediating the effects of glucocorticoids and insulin on IGFBP-1 promoter activity we created luciferase reporter gene constructs and performed transfection studies in H4IIE hepatoma cells. Initial studies confirmed that the IGFBP-1 promoter is functional when inserted in the correct orientation, but not in the reverse orientation. Dexamethasone (DEX) increased promoter activity 10-fold, and insulin reversed this effect of DEX by 85% at 8 h. The effects of DEX were abolished when constructs were truncated to 89 bases from the RNA cap site, and DNase footprinting with the DNA- binding domain of the human glucocorticoid receptor identified an imperfect palindrome containing two receptor-binding sites separated by three nucleotides typical of a glucocorticoid response element (GRE) at this location. Mutation of either binding site (or half-site) disrupted the effects of DEX, confirming that this sequence functions as a GRE. Two other regions of the promoter also footprinted with the glucocorticoid receptor protein and contained sequences consistent with glucocorticoid receptor-binding sites; however, neither of these footprints contained the full structure expected of a functional GRE, and neither mutation nor deletion of these other sequences altered the effects of DEX on promoter activity. To identify the DNA sequences required for the effects of insulin on glucocorticoid-stimulated promoter activity, we created internal deletions throughout the IGFBP-1 promoter region. Deletion of the 22-basepair (bp) sequence immediately 5' from the GRE disrupted the effect of insulin and appeared to increase basal promoter activity at least 2-fold in each of eight experiments (P < 0.001 vs. intact promoter). This region of the IGFBP-1 promoter contains a 19-bp palindrome (CAAAACAAACTTATTTTG) that overlaps the 5'-end of the GRE and is fully conserved in the human IGFBP-1 promoter. Each half of this palindrome resembles previously identified insulin response sequences, and deletion/mutation analysis suggests that each half may contribute to the effects of insulin on promoter activity. Gel shift studies confirmed that this palindrome binds H4IIE nuclear proteins. In summary, we have identified a GRE in the 5'- promoter region of the rat IGFBP-1 gene approximately 90 bp up-stream from the RNA cap site as well as a contiguous 22-bp region that plays a critical role in mediating the effects of insulin on glucocorticoid- stimulated promoter activity.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				M. Ono, D. J. Chia, R. Merino-Martinez, A. Flores-Morales, T. G. Unterman, and P. Rotwein Signal Transducer and Activator of Transcription (Stat) 5b-Mediated Inhibition of Insulin-Like Growth Factor Binding Protein-1 Gene Transcription: A Mechanism for Repression of Gene Expression by Growth Hormone Mol. Endocrinol., June 1, 2007; 21(6): 1443 - 1457. [Abstract] [Full Text] [PDF]

				Y. He and S. S. Simons Jr. STAMP, a Novel Predicted Factor Assisting TIF2 Actions in Glucocorticoid Receptor-Mediated Induction and Repression Mol. Cell. Biol., February 15, 2007; 27(4): 1467 - 1485. [Abstract] [Full Text] [PDF]

				G. SCHWEIZER-GROYER, G. FALLOT, F. CADEPOND, C. GIRARD, and A. GROYER The cAMP-Responsive Unit of the Human Insulin-Like Growth Factor-Binding Protein-1 Coinstitutes a Functional Insulin-Response Element Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 296 - 309. [Abstract] [Full Text] [PDF]

				A L Pierce, M Shimizu, L Felli, P Swanson, and W W Dickhoff Metabolic hormones regulate insulin-like growth factor binding protein-1 mRNA levels in primary cultured salmon hepatocytes; lack of inhibition by insulin. J. Endocrinol., November 1, 2006; 191(2): 379 - 386. [Abstract] [Full Text] [PDF]

				R. H. Stephens, P. McElduff, A. H. Heald, J. P. New, J. Worthington, W. E. Ollier, and J. M. Gibson Polymorphisms in IGF-Binding Protein 1 Are Associated With Impaired Renal Function in Type 2 Diabetes Diabetes, December 1, 2005; 54(12): 3547 - 3553. [Abstract] [Full Text] [PDF]

				L. Gan, H. Pan, and T. G. Unterman Insulin Response Sequence-Dependent and -Independent Mechanisms Mediate Effects of Insulin on Glucocorticoid-Stimulated Insulin-Like Growth Factor Binding Protein-1 Promoter Activity Endocrinology, October 1, 2005; 146(10): 4274 - 4280. [Abstract] [Full Text] [PDF]

				J.J. Kim, O.L. Buzzio, S. Li, and Z. Lu Role of FOXO1A in the Regulation of Insulin-Like Growth Factor-Binding Protein-1 in Human Endometrial Cells: Interaction with Progesterone Receptor Biol Reprod, October 1, 2005; 73(4): 833 - 839. [Abstract] [Full Text] [PDF]

				X. L. Wang, B. Herzog, M. Waltner-Law, R. K. Hall, M. Shiota, and D. K. Granner The Synergistic Effect of Dexamethasone and All-trans-retinoic Acid on Hepatic Phosphoenolpyruvate Carboxykinase Gene Expression Involves the Coactivator p300 J. Biol. Chem., August 13, 2004; 279(33): 34191 - 34200. [Abstract] [Full Text] [PDF]

				W.-C. Tsai, N. Bhattacharyya, L.-Y. Han, J. A. Hanover, and M. M. Rechler Insulin Inhibition of Transcription Stimulated by the Forkhead Protein Foxo1 Is Not Solely due to Nuclear Exclusion Endocrinology, December 1, 2003; 144(12): 5615 - 5622. [Abstract] [Full Text] [PDF]

				I. Rogatsky, J.-C. Wang, M. K. Derynck, D. F. Nonaka, D. B. Khodabakhsh, C. M. Haqq, B. D. Darimont, M. J. Garabedian, and K. R. Yamamoto Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor PNAS, November 25, 2003; 100(24): 13845 - 13850. [Abstract] [Full Text] [PDF]

				J. Altomonte, A. Richter, S. Harbaran, J. Suriawinata, J. Nakae, S. N. Thung, M. Meseck, D. Accili, and H. Dong Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E718 - E728. [Abstract] [Full Text] [PDF]

				W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1475 - 1484. [Abstract] [Full Text] [PDF]

				W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1475 - 1484. [Abstract] [Full Text]

				M. Waltner-Law, D. T. Duong, M. C. Daniels, B. Herzog, X. L. Wang, R. Prasad, and D. K. Granner Elements of the Glucocorticoid and Retinoic Acid Response Units Are Involved in cAMP-mediated Expression of the PEPCK Gene J. Biol. Chem., March 14, 2003; 278(12): 10427 - 10435. [Abstract] [Full Text] [PDF]

				J. J. Kim, H. S. Taylor, G. E. Akbas, I. Foucher, A. Trembleau, R. C. Jaffe, A. T. Fazleabas, and T. G. Unterman Regulation of Insulin-Like Growth Factor Binding Protein-1 Promoter Activity by FKHR and HOXA10 in Primate Endometrial Cells Biol Reprod, January 1, 2003; 68(1): 24 - 30. [Abstract] [Full Text] [PDF]

				L. E. L. Katz, D. D. DeLeon, H. Zhao, and A. F. Jawad Free and Total Insulin-Like Growth Factor (IGF)-I Levels Decline during Fasting: Relationships with Insulin and IGF-Binding Protein-1 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2978 - 2983. [Abstract] [Full Text] [PDF]

				E. Kajantie, L. Dunkel, E.-M. Rutanen, M. Seppala, R. Koistinen, A. Sarnesto, and S. Andersson IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2171 - 2179. [Abstract] [Full Text] [PDF]

				H. Schrem, J. Klempnauer, and J. Borlak Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression Pharmacol. Rev., March 1, 2002; 54(1): 129 - 158. [Abstract] [Full Text] [PDF]

				Z. Yang, J. Whelan, R. Babb, and B. R. Bowen An mRNA Splice Variant of the AFX Gene with Altered Transcriptional Activity J. Biol. Chem., March 1, 2002; 277(10): 8068 - 8075. [Abstract] [Full Text] [PDF]

				W. Y. Almawi and O. K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor J. Leukoc. Biol., January 1, 2002; 71(1): 9 - 15. [Abstract] [Full Text] [PDF]

				T. Matsukawa, Y. Inoue, Y. Oishi, H. Kato, and T. Noguchi Up-Regulation of Upstream Stimulatory Factors by Protein Malnutrition and Its Possible Role in Regulation of the IGF-Binding Protein-1 Gene Endocrinology, November 1, 2001; 142(11): 4643 - 4651. [Abstract] [Full Text] [PDF]

				M. Tomizawa, A. Kumar, V. Perrot, J. Nakae, D. Accili, and M. M. Rechler Insulin Inhibits the Activation of Transcription by a C-terminal Fragment of the Forkhead Transcription Factor FKHR. A MECHANISM FOR INSULIN INHIBITION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 TRANSCRIPTION J. Biol. Chem., March 15, 2000; 275(10): 7289 - 7295. [Abstract] [Full Text] [PDF]

				S. R. Datta, A. Brunet, and M. E. Greenberg Cellular survival: a play in three Akts Genes & Dev., November 15, 1999; 13(22): 2905 - 2927. [Full Text]

				S. K. Durham, A. Suwanichkul, A. O. Scheimann, D. Yee, J. G. Jackson, F. G. Barr, and D. R. Powell FKHR Binds the Insulin Response Element in the Insulin-Like Growth Factor Binding Protein-1 Promoter Endocrinology, July 1, 1999; 140(7): 3140 - 3146. [Abstract] [Full Text]

				G. Schweizer-Groyer, N. Jibard, E. Neau, D. Fortin, F. Cadepond, E.-E. Baulieu, and A. Groyer The Glucocorticoid Response Element II Is Functionally Homologous in Rat and Human Insulin-like Growth Factor-binding Protein-1 Promoters J. Biol. Chem., April 23, 1999; 274(17): 11679 - 11686. [Abstract] [Full Text] [PDF]

				L. E. Levitt Katz, M. S. Satin-Smith, P. Collett-Solberg, L. Baker, C. A. Stanley, and P. Cohen Dual Regulation of Insulin-Like Growth Factor Binding Protein-1 Levels by Insulin and Cortisol during Fasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4426 - 4430. [Abstract] [Full Text]

				M. Dickens, C. A. Svitek, A. A. Culbert, R. M. O'Brien, and J. M. Tavare Central Role for Phosphatidylinositide 3-Kinase in the Repression of Glucose-6-phosphatase Gene Transcription by Insulin J. Biol. Chem., August 7, 1998; 273(32): 20144 - 20149. [Abstract] [Full Text] [PDF]

				R. S. Streeper, E. M. Eaton, D. H. Ebert, S. C. Chapman, C. A. Svitek, and R. M. O'Brien Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription PNAS, August 4, 1998; 95(16): 9208 - 9213. [Abstract] [Full Text] [PDF]

				Y. Kumei, H. Shimokawa, H. Katano, H. Akiyama, M. Hirano, C. Mukai, S. Nagaoka, P. A. Whitson, and C. F. Sams Spaceflight modulates insulin-like growth factor binding proteins and glucocorticoid receptor in osteoblasts J Appl Physiol, July 1, 1998; 85(1): 139 - 147. [Abstract] [Full Text] [PDF]

				F. A. Simmen, L. Badinga, M. L. Green, I. Kwak, S. Song, and R. C. M. Simmen The Porcine Insulin-Like Growth Factor System: At the Interface of Nutrition, Growth and Reproduction J. Nutr., February 1, 1998; 128(2): 315 - 315. [Abstract] [Full Text]

				D.-S. Suh and M. M. Rechler Hepatocyte Nuclear Factor 1 and the Glucocorticoid Receptor Synergistically Activate Transcription of the Rat Insulin-like Growth Factor Binding Protein-1 Gene Mol. Endocrinol., November 1, 1997; 11(12): 1822 - 1831. [Abstract] [Full Text]

				S. V. Allander, S. K. Durham, A. O. Scheimann, R. M. Wasserman, A. Suwanichkul, and D. R. Powell Hepatic Nuclear Factor 3 and High Mobility Group I/Y Proteins Bind the Insulin Response Element of the Insulin-Like Growth Factor-Binding Protein-1 Promoter Endocrinology, October 1, 1997; 138(10): 4291 - 4300. [Abstract] [Full Text] [PDF]

				R. S. Streeper, C. A. Svitek, S. Chapman, L. E. Greenbaum, R. Taub, and R. M. O'Brien A Multicomponent Insulin Response Sequence Mediates a Strong Repression of Mouse Glucose-6-phosphatase Gene Transcription by Insulin J. Biol. Chem., May 2, 1997; 272(18): 11698 - 11701. [Abstract] [Full Text] [PDF]

				B. C. Villafuerte, W. Zhao, A. C. Herington, R. Saffery, and L. S. Phillips Identification of an Insulin-responsive Element in the Rat Insulin-like Growth Factor-binding Protein-3 Gene J. Biol. Chem., February 21, 1997; 272(8): 5024 - 5030. [Abstract] [Full Text] [PDF]

				R. K. Hall, T. Yamasaki, T. Kucera, M. Waltner-Law, R. O'Brien, and D. K. Granner Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin. THE ROLE OF WINGED HELIX/FORKHEAD PROTEINS J. Biol. Chem., September 22, 2000; 275(39): 30169 - 30175. [Abstract] [Full Text] [PDF]

				A. K. Ghosh, R. Lacson, P. Liu, S. B. Cichy, A. Danilkovich, S. Guo, and T. G. Unterman A Nucleoprotein Complex containing CCAAT/Enhancer-binding Protein beta Interacts with an Insulin Response Sequence in the Insulin-like Growth Factor-binding Protein-1 Gene and Contributes to Insulin-regulated Gene Expression J. Biol. Chem., March 9, 2001; 276(11): 8507 - 8515. [Abstract] [Full Text] [PDF]

				D. Yeagley, S. Guo, T. Unterman, and P. G. Quinn Gene- and Activation-specific Mechanisms for Insulin Inhibition of Basal and Glucocorticoid-induced Insulin-like Growth Factor Binding Protein-1 and Phosphoenolpyruvate Carboxykinase Transcription. ROLES OF FORKHEAD AND INSULIN RESPONSE SEQUENCES J. Biol. Chem., August 31, 2001; 276(36): 33705 - 33710. [Abstract] [Full Text] [PDF]